ERBB2 and breast cancer: BC is divided into 4 intrinsic subtypes with a molecular basis as follows: luminal A (LA), luminal B (LB), human epidermal growth factor receptor 2 (HER2)-enriched, and basal-like (BL) BC [35–38].